Found 5 matching trials
A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. PHASE3 This was a randomized, double-blind, parallel, multicenter, multinational s...
Show More Location
AES - DRS - Medical Center Synexus Sofia EOOD
Learn More & Join Trial
Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects PHASE1 This study is to compare PK, PD, safety, tolerability, and immunogenicity p...
Show More Learn More & Join Trial
A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva PHASE1 Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Show More Location
Biokinetica - Early Phase Institute
Learn More & Join Trial
Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® PHASE1 A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-...
Show More Location
Xentria Investigative Site
Learn More & Join Trial
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers PHASE1 This is a randomized, double-blind, three-arm, parallel-group, single-dose ...
Show More Learn More & Join Trial